DSV opens direct Luxembourg-Indianapolis pharma air route

DSV launched a new Air ThermoDirect connection through Indianapolis International Airport to strengthen temperature-controlled pharmaceutical shipping between Luxembourg and the U.S. hub. The route is designed to improve cold-chain reliability, lower handling risk and reduce costs and emissions on critical healthcare lanes.

Why it matters: - The new route gives pharmaceutical shippers a more controlled lane between Europe and the U.S. Midwest. - DSV says the service is meant to protect temperature-sensitive therapies while reducing operational uncertainty, total cost and emissions. - Indianapolis gains a larger role as a life sciences logistics hub in the global cold chain.

What happened: - DSV expanded its Air ThermoDirect solution through Indianapolis International Airport. - The company launched a direct pharmaceutical air connection between Luxembourg and Indianapolis. - The announcement was dated June 9, 2026. - DSV said the Indianapolis operations will support the global Air ThermoDirect healthcare network.

The details: - The route is designed to minimize time spent in uncontrolled environments. - The service removes the complexity of active containers, according to DSV. - DSV said the lane creates a predictable and scalable cold chain. - The company said optimized handling and more sustainable thermal solutions will help reduce environmental impact. - Kenneth Källström, DSV executive vice president and global head of healthcare, said the Indianapolis hub will enhance end-to-end visibility and control across pharma manufacturing regions in the U.S., Europe, the Americas and APAC. - Källström said the network is intended to help life-saving therapies move with greater speed, reliability and integrity. - Stephanie Penarete, vice president air product Americas, said Indy Wings reflects DSV’s strategy to bring critical supply-chain points under full accountability. - Penarete said the company is linking key pharmaceutical hubs with greater precision, resilience and excellence.

Between the lines: - The launch shows how pharma logistics is shifting from simple capacity toward tighter control over temperature, visibility and handling. - DSV is using Indianapolis to deepen its footprint in a fast-growing U.S. healthcare logistics market. - The emphasis on sustainable thermal solutions suggests customers are being pushed to balance cold-chain performance with emissions goals.

What’s next: - DSV is expected to keep building out its Air ThermoDirect healthcare network across major pharma regions. - The Indianapolis route may serve as a model for additional controlled-temperature lanes if demand grows. - DSV provided media contacts for Sofia Fritze and Rebecca Ann Martin in the announcement.